Progenesis, Inc. Receives Accreditation from College of American Pathologists (CAP)

La Jolla, CA — October 17, 2018 — Progenesis, Inc, an industry leader in reproductive genetics, announced today that its clinical laboratory has received accreditation from the College of American Pathologists (CAP), meeting the highest standard of excellence in clinical laboratory practices. This accreditation comes after successful completion of the CAP inspection process and adds Progenesis, Inc, to an elite group of laboratories that operate at the greatest level of quality standards.

The CAP Laboratory Accreditation Process is an international program designed to recognize clinical labs that have achieved quality beyond that which is required for regulatory compliance. During the accreditation process, inspectors meticulously examine the clinical laboratory’s records and quality control procedures. They also assess the laboratory’s staff qualifications, equipment, facilities, safety program, and overall management to ensure it meets CAP’s diverse and stringent requirements.

“In the last few years, Progenesis’ highest priority was to develop stringent quality control and quality assurance programs with a fully automated LIMS [Laboratory Information Management Solution]. CAP accreditation was a necessary step to enforce our commitment to quality,” said Dr. Nabil Arrach, CEO at Progenesis, Inc.

About the College of American Pathologists — The College of American Pathologists (CAP) was founded in 1946 and is the world’s largest organization composed exclusively of pathologists certified by the American Board of Pathology. It is widely considered to be the leader in laboratory quality assurance. The CAP is an advocate for high-quality and cost-effective medical care. For more information, visit www.cap.org.

About Progenesis — Founded in 2015, Progenesis, Inc, is an industry leader in reproductive genetics. The San Diego based company uses cutting-edge technology to develop and offer a wide range of non-invasive, customizable genetic tests and services for patients on their family planning journey. Progenesis, Inc, is the first company in the U.S. to offer Next Generation Sequencing (NGS) for preimplantation genetic screening (PGS) and preimplantation genetic diagnosis (PGD), offering the most accurate testing in the IVF field. The company’s clinical lab is CLIA licensed and CAP accredited. Learn more at www.progenesis.com

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *